SCOPUS 정보 검색 플랫폼

Blood

Volumn 114, Issue 14, 2009, Pages 2857-2858

Screens, iron, and leukemia

(2) Stone, Richard M a DeAngelo, Daniel J a

a DANA FARBER CANCER INSTITUTE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTIFUNGAL AGENT; ANTISENSE OLIGONUCLEOTIDE; CICLOPIROX; CYTARABINE; DEFEROXAMINE; DEXAMETHASONE; DIHYDROFOLATE REDUCTASE INHIBITOR; GEFITINIB; HYDROXYUREA; IRON; SURVIVIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; CELL LEVEL; CYTOTOXICITY; HELA CELL; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA; NOTE; ONCOGENE; PRIORITY JOURNAL; SCREENING;

EID: 70449502620 PISSN: 00064971 EISSN: 15280020 Source Type: Journal
DOI: 10.1182/blood-2009-08-234161 Document Type: Note

Times cited : (1)

References (6)

1
- 70449466605
- Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells
- Eberhard Y, McDermott SP, Wang X, et al. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells. Blood. 2009;114(14):3064-3073.
- (2009) Blood , vol.114 , Issue.14 , pp. 3064-3073
- Eberhard, Y.¹ McDermott, S.P.² Wang, X.³

2
- 34548091013
- Anticancer medicines in development: Assessment of bioactivity profiles within the National Cancer Institute anticancer screening data
- DOI 10.1158/1535-7163.MCT-06-0787
- Covell DG, Huang R, Wallqvist A. Anticancer medicines in development: assessment of bioactivity profiles within the National Cancer Institute anticancer screening data. Mol Cancer Ther. 2007;6(8):2261-2270. (Pubitemid 47294754)
- (2007) Molecular Cancer Therapeutics , vol.6 , Issue.8 , pp. 2261-2270
- Covell, D.G.¹ Huang, R.² Wallqvist, A.³

3
- 42249104213
- A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemia
- DOI 10.1158/1078-0432.CCR-07-1320
- Klisovic RB, Blum W, Wei X, et al. Phase I study of GTI-2040, an antisense to ribonucleotide reductase, in combination with high-dose cytarabine in patients with acute myeloid leukemia. Clin Cancer Res. 2008;14(12):3889-3895. (Pubitemid 351551079)
- (2008) Clinical Cancer Research , vol.14 , Issue.8 , pp. 2444-2449
- Klisovic, R.B.¹ Stock, W.² Cataland, S.³ Klisovic, M.I.⁴ Liu, S.⁵ Blum, W.⁶ Green, M.⁷ Odenike, O.⁸ Godley, L.⁹ Vanden Burgt, J.¹⁰ Van Laar, E.¹¹ Cullen, M.¹² Macleod, A.R.¹³ Besterman, J.M.¹⁴ Reid, G.K.¹⁵ Byrd, J.C.¹⁶ Marcucci, G.¹⁷

4
- 47749109128
- Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation
- Hahn CK, Ross KN, Warrington IM, et al. Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation. Proc Natl Acad SciU S A. 2008;105(28):9751-9756.
- (2008) Proc Natl Acad SciU S A , vol.105 , Issue.28 , pp. 9751-9756
- Hahn, C.K.¹ Ross, K.N.² Warrington, I.M.³

5
- 27144443376
- Gefitinib induces myeloid differentiation of acute myeloid leukemia
- DOI 10.1182/blood-2005-02-0488
- Stegmaier K, Corsello SM, Ross KN, Wong JS, DeAngelo DJ, Golub TR. Gefitinib induces myeloid differentiation of acute myeloid leukemia. Blood. 2005;106(8):2841-2848. (Pubitemid 41510762)
- (2005) Blood , vol.106 , Issue.8 , pp. 2841-2848
- Stegmaier, K.¹ Corsello, S.M.² Ross, K.N.³ Wong, J.S.⁴ Deangelo, D.J.⁵ Golub, T.R.⁶

6
- 67650379749
- Identification of AML1-ETO modulators by chemical genomics
- Corsello SM, Roti G, Ross KN, et al. Identification of AML1-ETO modulators by chemical genomics. Blood. 2009;113(24):6193-6205.
- (2009) Blood , vol.113 , Issue.24 , pp. 6193-6205
- Corsello, S.M.¹ Roti, G.² Ross, K.N.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.